Cesca Therapeutics Files Patent to Simplify Development of CAR T-cell Immunotherapies – Immuno-Oncology News
Immuno-Oncology News |
Cesca Therapeutics Files Patent to Simplify Development of CAR T-cell Immunotherapies
Immuno-Oncology News Cesca Therapeutics filed a new patent application that may simplify the development of cancer immunotherapies, potentially improving efficiency and reducing manufacturing costs, the company announced. The application was submitted to the U.S. Patent … |
